| Filer | Ownership | Change % | Holdings Value | Net Change | Nb Shares | Change % | Reporting Name | Report Period |
|---|---|---|---|---|---|---|---|---|
| MARSHALL WACE, LLP | 10% | $67,729,915 | 28,103,699 | MARSHALL WACE, LLP | 30 Sep 2025 | |||
| Rosalind Advisors, Inc. | 9.9% | +5.6% | $25,929,565 | 10,987,104 | 0% | Rosalind Advisors, Inc. | 01 Aug 2025 | |
| Nantahala Capital Management, LLC | 10% | 0% | $10,256,307 | +$2,934,884 | 4,255,729 | +40% | Nantahala Capital Management, LLC | 30 Sep 2025 |
| Lawless Michael A | 8.6% | $8,711,502 | 3,614,731 | Michael A. Lawless | 26 Jun 2025 | |||
| Aberdeen Group plc | 6% | $5,979,492 | 2,481,117 | Aberdeen Group plc | 01 Oct 2025 | |||
| Parkman Healthcare Partners LLC | 5.8% | $5,881,926 | 2,440,633 | Parkman Healthcare Partners LLC | 30 Sep 2025 | |||
| Nantahala Capital Partners Limited Partnership | 5.7% | $5,827,419 | 2,418,016 | NANTAHALA CAPITAL PARTNERS LIMITED PARTNERSHIP | 30 Sep 2025 | |||
| Velan Capital Investment Management LP | 5.1% | $5,059,127 | 2,143,698 | Velan Capital Master Fund LP | 30 Jul 2025 | |||
| ORBIMED ADVISORS LLC | 4.1% | -44% | $5,141,506 | 2,133,405 | 0% | OrbiMed Advisors LLC | 30 Sep 2025 | |
| Shore Craig | 3.5% | $3,577,657 | 1,484,505 | Craig Shore | 26 Jun 2025 |
As of 30 Sep 2025, 40 institutional investors reported holding 22,730,210 shares of InspireMD, Inc. - Common Stock, $0.0001 par value (NSPR). This represents 54% of the company’s total 42,079,879 outstanding shares.
The largest institutional shareholders of InspireMD, Inc. - Common Stock, $0.0001 par value (NSPR) together control 54% of the company’s outstanding shares — a level of ownership often associated with strong institutional conviction and long‑term capital commitment.
| Institution | Ownership % | Shares Held | Share Change % | Portfolio % | Holdings Value |
|---|---|---|---|---|---|
| Rosalind Advisors, Inc. | 9.3% | 3,905,743 | +71% | 3.4% | $9,412,840 |
| Nantahala Capital Management, LLC | 8% | 3,376,484 | +46% | 0.5% | $8,137,327 |
| Aberdeen Group plc | 5.9% | 2,481,117 | 0.01% | $5,979,492 | |
| Parkman Healthcare Partners LLC | 5.8% | 2,440,633 | +98% | 0.65% | $5,881,926 |
| Velan Capital Investment Management LP | 5.1% | 2,143,698 | +137% | 4.9% | $5,166,312 |
| ORBIMED ADVISORS LLC | 5.1% | 2,133,405 | 0% | 0.12% | $5,141,506 |
| MARSHALL WACE, LLP | 4.4% | 1,860,405 | 0% | 0% | $4,483,576 |
| Soleus Capital Management, L.P. | 3.5% | 1,470,934 | -22% | 0.19% | $3,544,951 |
| Ghisallo Capital Management LLC | 2.2% | 921,587 | 0.07% | $2,221,025 | |
| PURA VIDA INVESTMENTS, LLC | 1.1% | 450,517 | 0% | 7% | $1,085,746 |
| Huntleigh Advisors, Inc. | 0.63% | 264,004 | +113% | 0.11% | $636,250 |
| Affiance Financial, LLC | 0.59% | 250,370 | +32% | 0.11% | $603,392 |
| INGALLS & SNYDER LLC | 0.53% | 225,002 | 0.02% | $542,000 | |
| MILLENNIUM MANAGEMENT LLC | 0.35% | 147,423 | +766% | 0% | $355,289 |
| Schonfeld Strategic Advisors LLC | 0.2% | 86,092 | +130% | 0% | $207,480 |
| MORGAN STANLEY | 0.2% | 86,011 | -8.6% | 0% | $207,286 |
| IRONWOOD INVESTMENT MANAGEMENT LLC | 0.15% | 61,579 | +1.7% | 0.06% | $148,405 |
| COURIER CAPITAL LLC | 0.13% | 55,000 | +83% | 0.01% | $132,550 |
| BlackRock, Inc. | 0.13% | 53,714 | +47% | 0% | $129,451 |
| VESTIA PERSONAL WEALTH ADVISORS | 0.1% | 42,425 | +136% | 0.06% | $102,244 |
| CITADEL ADVISORS LLC | 0.09% | 37,954 | +45% | 0% | $91,469 |
| NORTHERN TRUST CORP | 0.08% | 33,572 | -26% | 0% | $80,909 |
| COMMONWEALTH EQUITY SERVICES, LLC | 0.08% | 32,550 | 0% | $78,000 | |
| Mesirow Financial Investment Management, Inc. | 0.07% | 30,000 | 0% | 0% | $72,300 |
| Uniting Wealth Partners, LLC | 0.05% | 21,066 | 0.01% | $50,769 |
| Period | Reported Shares, Excl. Options | Value, Excl. Options | Value Change | Price (Median) | Investors |
|---|---|---|---|---|---|
| 2025 Q4 | 3,443,517 | $6,129,461 | +$1,232,200 | $1.78 | 4 |
| 2025 Q3 | 22,730,210 | $54,778,990 | +$20,913,736 | $2.41 | 40 |
| 2025 Q2 | 14,061,920 | $31,922,818 | +$2,512,314 | $2.27 | 36 |
| 2025 Q1 | 12,917,013 | $34,746,467 | +$554,615 | $2.69 | 34 |
| 2024 Q4 | 12,710,904 | $33,407,511 | +$811,860 | $2.63 | 29 |
| 2024 Q3 | 12,402,374 | $33,215,449 | +$1,209,473 | $2.68 | 27 |
| 2024 Q2 | 11,951,922 | $29,859,952 | +$4,430,429 | $2.50 | 23 |
| 2024 Q1 | 10,178,288 | $23,962,111 | -$399,400 | $2.37 | 25 |
| 2023 Q4 | 10,339,444 | $29,052,785 | +$1,719,804 | $2.81 | 27 |
| 2023 Q3 | 8,762,240 | $28,676,783 | +$2,327,230 | $3.27 | 25 |
| 2023 Q2 | 8,054,251 | $20,221,241 | +$20,007,582 | $2.51 | 22 |
| 2023 Q1 | 88,752 | $103,127 | -$54,760 | $1.12 | 12 |
| 2022 Q4 | 155,809 | $137,173 | +$21,576 | $0.86 | 14 |
| 2022 Q3 | 112,334 | $168,630 | -$78,516 | $1.50 | 11 |
| 2022 Q2 | 129,060 | $256,202 | -$10,358 | $1.99 | 10 |
| 2022 Q1 | 140,275 | $455,524 | -$96,895 | $3.21 | 13 |
| 2021 Q4 | 172,505 | $527,325 | -$27,335 | $3.02 | 15 |
| 2021 Q3 | 170,103 | $703,514 | -$1,360,154 | $4.10 | 12 |
| 2021 Q2 | 450,832 | $2,277,560 | +$2,277,560 | $5.05 | 14 |